What Isomorphic Labs does
Isomorphic Labs, a Google DeepMind spinout led by Demis Hassabis, develops AI models for drug discovery, including its Drug Design Engine (IsoDDE), which extends the company's AlphaFold foundation to predict molecular design and drug performance. The company says the engine has hit key internal milestones and identified viable drug candidates faster than traditional methods. Isomorphic Labs operates as a biotech partner to pharmaceutical companies rather than selling a self-serve software product. The company was founded in London in 2021.
Isomorphic Labs is a healthcare tool on Falcoscan. AI drug design engine spun out of Google DeepMind. Falcoscan rates Isomorphic Labs with an Opportunity score of 86/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Isomorphic Labs is founded in 2021, currently at Series_b stage. Pricing: Paid.